Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-11-25

FDA Approved: ATENOLOL AND CHLORTHALIDONE — Original Application (Unichem Pharmaceuticals (USA), Inc.)

View source ↗

Summary

FDA approves a generic fixed-dose combination of atenolol and chlorthalidone for the treatment of hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ATENOLOL AND CHLORTHALIDONE (Atenolol and chlorthalidone)

Snippet

ORIG AP for ATENOLOL AND CHLORTHALIDONE (ATENOLOL AND CHLORTHALIDONE)